Back to search

France· FR:61094142

PENTAMIDINE TILLOMED 300 mg, poudre pour solution injectable/pour perfusion ou pour inhalation par nébuliseur

A medicinal product containing diiséthionate de pentamidine, registered in France by TILLOMED PHARMA (ALLEMAGNE), on the national reimbursement list.

Reimbursed in France (Assurance maladie)

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedPENTAMIDINE TILLOMED 300 mg, poudre p…ATC—REGISTER NO.FR:61094142PACKS LISTED1CHECKEDSeptember 12, 2026

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
DIISÉTHIONATE DE PENTAMIDINE
Manufacturer
TILLOMED PHARMA (ALLEMAGNE)
Country
France (FR)
ATC code
—
Reimbursed
Yes
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • cip13
    3400930255346
    1 flacon(s) en verre de 20 ml
    EUR 12.26

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Diiséthionate de pentamidine in 8 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All diiséthionate de pentamidine products

Authorised across Europe · EMA

The same active substance is authorised in 12 EEA countries. Names it is sold under:

  • Belgium · Pentacarinat
  • Germany · Pentacarinat, Pentamidindiisetionat Tillomed
  • Denmark · Pentamidine Tillomed
  • Spain · Pentacarinat
  • Finland · Pentamidine Tillomed
  • United Kingdom (Northern Ireland) · Pentamidine Isetionate Tillomed
  • Ireland · Pentamidine Tillomed
  • Italy · Pentacarinat
  • Luxembourg · Pentacarinat
  • Netherlands · Pentacarinat, Pentamidinediisetionaat Tillomed
  • Norway · Pentamidine Diisetionate Tillomed
  • Sweden · Pentamidine Tillomed

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/78a5e167-2730-477f-9203-89930998ed67
GET /v1/drugs/78a5e167-2730-477f-9203-89930998ed67?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "61094142",
  "date_amm": "2022-06-20",
  "type_amm": "Procédure décentralisée",
  "numero_ue": null,
  "substance": "DIISÉTHIONATE DE PENTAMIDINE",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "poudre pour solution injectable pour perfusion ou pour inhalation par nébuliseur",
  "voies_administration": "inhalée;intramusculaire;intraveineuse",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}

See everything about diiséthionate de pentamidine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.